Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Vancomycin and the Immune–Microbiome Translation Gap
2026-08-13
Vancomycin offers a precise bacterial cell wall perturbation for resistance and microbiome research, but translating antibiotic-associated immune findings requires disciplined controls. This article connects peptidoglycan precursor binding with the Th1/Th2 and gut-flora findings reported in an allergic rhinitis rat study while defining a practical path toward more interpretable translational experiments.
-
Step Biosensor Tracks Native Protein Dynamics
2026-08-13
The reference study introduces circStep, an allosteric genetically encoded biosensor that converts endogenous protein binding into fluorescence from a dual-locked fluorogenic RNA aptamer module. This design enables live-cell visualization of native protein abundance, localization, and relocalization without directly tagging or overexpressing the protein of interest.
-
Prednisolone Workflows for Glucocorticoid Research
2026-08-12
Prednisolone provides a high-purity synthetic glucocorticoid control for dissecting receptor signaling, inflammatory phenotypes, and cellular responses alongside emerging ERAD-based degradation assays. This workflow-focused guide shows how to use it as a pathway comparator without mistakenly treating it as the desonide-derived ERAD warhead described in the reference study.
-
Gepotidacin (GSK2140944) Research Workflows
2026-08-12
Gepotidacin enables mechanism-led antibacterial research from bacterial growth inhibition to DNA gyrase cleavage assays. This workflow connects dose-response screening, resistance analysis, and translational interpretation while emphasizing compound handling and assay troubleshooting.
-
AZD0156: A Translational Strategy for ATM Inhibition
2026-08-11
AZD0156 offers a highly selective way to interrogate ATM kinase biology, connect DNA double-strand break repair with metabolic adaptation, and design more informative combination studies in cancer therapy research.
-
STT3B, ICG, and α-Amanitin Cytotoxicity
2026-08-11
The reference study combines a genome-wide CRISPR knockout screen, computational drug screening, and validation in cells, liver organoids, and mice to identify STT3B as a critical determinant of α-amanitin toxicity. Its findings position indocyanine green as a candidate STT3B inhibitor and provide a mechanistic framework for studying mushroom toxin cytotoxicity beyond direct RNA polymerase II inhibition.
-
JTW and Coptisine Rewire PCOS Steroidogenesis
2026-08-10
The 2025 Phytomedicine study identifies SIRT1 ubiquitination and mitochondrial cholesterol import as a mechanistic link between Jiao-tai-wan, coptisine, and abnormal ovarian steroidogenesis in a DHEA-induced PCOS rat model. Its integrated animal, cellular, transcriptomic, imaging, and target-validation strategy provides a useful framework for studying how mitochondrial steroidogenic control contributes to PCOS phenotypes.
-
Hippo Signaling in Hepatobiliary Cell Maturation
2026-08-09
This preprint identifies two largely independent Hippo pathway modules, HPO1 and HPO2, as stage- and cell-type-specific checkpoints for hepatocyte and cholangiocyte maturation. Spatial transcriptomics and imaging in genetically perturbed mouse livers reveal distinct immature cell states that also emerge during regeneration, refining the view of Hippo signaling beyond simple control of organ size.
-
Prochlorperazine: Applied Cell Research Workflows
2026-08-08
Prochlorperazine is a dopamine D2 receptor antagonist with practical value across antiemetic therapy, melanoma research, and mechanistic membrane-trafficking assays. This workflow-focused guide explains solvent handling, concentration selection, assay controls, and how to translate clinical-study design principles into reproducible laboratory experiments.
-
Bortezomib (PS-341) for Proteostasis Assays
2026-08-07
Bortezomib (PS-341) provides a reversible 20S proteasome perturbation for connecting protein turnover, apoptosis, and neuronal stress phenotypes. This workflow positions it as an orthogonal tool alongside DCPS/TDP-43 genetic experiments rather than as a direct P-body pathway inhibitor.
-
L-NAME Hydrochloride: Reliable NOS Inhibition for Cell Viabi
2026-08-07
This article addresses common laboratory challenges in cell viability, proliferation, and cytotoxicity studies, focusing on the reproducibility and data integrity enabled by L-NAME Hydrochloride (SKU A7088). Using scenario-driven Q&A, we provide evidence-based insights for selecting, optimizing, and interpreting results with this benchmark NOS inhibitor—grounded in quantitative data and direct protocol guidance.
-
A40926: Dalbavancin Precursor for Gram-Positive Pathogen Res
2026-08-06
A40926 is a natural glycopeptide antibiotic and the direct precursor to dalbavancin, exhibiting potent and well-characterized bactericidal activity against Gram-positive bacteria and Neisseria gonorrhoeae. Its precise inhibition of bacterial cell wall synthesis and pathogen-specific MIC values make it indispensable for in vitro antibacterial assays and advanced antibiotic development.
-
Bortezomib (PS-341): Applied Proteasome Inhibition in Cancer
2026-08-06
Bortezomib (PS-341) delivers robust, selective 20S proteasome inhibition, enabling high-sensitivity apoptosis and cell viability assays across cancer models. This article translates recent mechanistic insights and workflow advances into actionable protocols and troubleshooting strategies, spotlighting how Bortezomib from APExBIO empowers reproducible research.
-
Doxorubicin Hydrochloride: Applied Workflows in Chemotherapy
2026-08-05
Harness the power of Doxorubicin hydrochloride in both cancer chemotherapy research and cardiotoxicity modeling. This article delivers actionable workflow enhancements, protocol optimization, and troubleshooting strategies to maximize experimental reproducibility and mechanistic insight.
-
Pronase E Protease Mixture: Precision in Unbiased Protein Di
2026-08-05
Explore the advanced science and workflow impact of Pronase E, a potent protease mixture, for protein sample preparation and proteomic innovation. This cornerstone article offers unique mechanistic insights and practical guidance for researchers seeking superior results.